Reaction

Device Connection Issue reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,026 reports · 47 co-occurring drugs

As of the last recalculation, Device Connection Issue appears in 2,026 FAERS reports alongside 47 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 57.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Epoprostenol	71	57.7	58.0
Copper	197	51.9	52.1
Carbidopa And Levodopa	127	29.3	29.3
0Xygen	110	24.2	24.3
Oxygen	110	24.2	24.3
Treprostinil	259	24.2	24.2
Ketoprofen	29	23.0	23.1
Leuprolide Acetate	153	21.8	21.9
Rasagiline Mesylate	23	21.5	21.5
Rotigotine	29	20.9	20.9
Somatropin	126	18.7	18.8
Pramipexole	25	17.0	17.0
Rivastigmine	29	16.0	16.1
Sildenafil	84	15.5	15.5
Amitriptyline Hydrochloride	25	14.8	14.8
Amikacin	23	14.0	14.0
Amantadine	20	13.4	13.4
Macitentan	85	13.1	13.1
Levodopa	14	12.0	12.0
Riociguat	37	11.9	11.9
Tadalafil	109	11.8	11.8
Sildenafil Powder,	37	10.9	10.9
Torsemide	33	10.4	10.4
Sildenafil Citrate	110	9.3	9.3
Metolazone	10	9.2	9.2
Clonidine	43	8.8	8.8
Norepinephrine Bitartrate	12	8.6	8.6
Cyclobenzaprine Hydrochloride	7	8.0	8.0
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	24	8.0	8.0
Baclofen	65	8.0	8.0
Sodium Chloride Tablet	54	7.7	7.7
Sodium Chloride Tablets	54	7.7	7.7
Norepinephrine	8	7.7	7.7
Sodium Chloride	56	7.5	7.5
Ropinirole	11	7.4	7.4
Ambrisentan	86	7.3	7.3
Cetirizine Hcl	6	6.7	6.7
Bupivacaine	6	6.6	6.6
Benzonatate	10	6.2	6.2
Blinatumomab	6	5.9	5.9
Bosentan	24	4.9	4.9
Selexipag	12	4.8	4.8
Teduglutide	6	4.6	4.6
Medroxyprogesterone Acetate	20	4.2	4.2
Methoxy Polyethylene Glycol-Epoetin Beta	3	2.8	2.8
Droxidopa	4	1.9	1.9
Pimavanserin Tartrate	5	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.